Rickets

1. High-Yield Summary

• Cardinal Pathophysiological Defect: Rickets represents a disorder of defective mineralization of the cartilaginous growth plate (physis) during endochondral ossification, occurring exclusively prior to physeal fusion. It is characterized by failure of calcium-phosphate hydroxyapatite crystallization within the zone of provisional calcification, resulting in chondrocyte apoptosis failure, massive hypertrophic physeal expansion, and secondary osteomalacia in cortical bone.
• Calcipenic vs. Phosphopenic Divergence: Extracellular hypophosphatemia is the shared proximate trigger arresting chondrocyte apoptosis. In calcipenic rickets (nutritional deficiency, VDDR-1, VDDR-2), hypophosphatemia is secondary to parathyroid hormone (PTH)-driven renal phosphate wasting. In phosphopenic rickets (XLH, ADHR, ARHR), primary renal phosphate wasting is mediated directly by excess fibroblast growth factor 23 (FGF23) suppressing NaPi-IIa/c cotransporters and 1-alpha-hydroxylase.
• The Mandatory Metabolic Stabilization Rule: Deformity correction surgery is absolutely contraindicated during active, metabolically unhealed rickets. Elective operative intervention must be deferred until serum alkaline phosphatase (ALP) and parathyroid hormone normalize and standing radiographs confirm complete reconstitution of the razor-sharp zone of provisional calcification (minimum 6 to 12 months of metabolic stability) to prevent catastrophic hardware failure and nonunion.
• Guided Growth Treatment Paradigm: Extraperiosteal tension-band plating (temporary hemiepiphysiodesis) is the first-line operative modality for progressive genu varum or genu valgum in skeletally immature patients with open physes. Angular correction occurs at approximately half the velocity observed in idiopathic cohorts (0.5° to 0.7° per month) and carries a rebound deformity rate exceeding 30% to 40%, mandating deliberate 2° to 3° overcorrection prior to implant removal.
• Targeted Biological Pharmacotherapy: Burosumab, a fully human monoclonal IgG1 antibody targeting circulating intact FGF23, represents the contemporary standard of care for pediatric X-linked hypophosphatemia. Biweekly subcutaneous administration normalizes renal phosphate reabsorption (TmP/GFR), heals the rachitic physis, and corrects lower extremity bowing without inducing the nephrocalcinosis and tertiary hyperparathyroidism that frequently complicate conventional oral phosphate and calcitriol therapy.

2. Anatomy

Physeal Zonal Microarchitecture and the Rachitic Defect

The normal cartilaginous growth plate is organized into four distinct histological strata that mediate longitudinal endochondral ossification:

• Reserve (Germinal) Zone: Situated adjacent to the epiphyseal secondary ossification center, containing quiescent spherical chondrocytes embedded in a rich type II collagen and proteoglycan matrix. These cells function as metabolic reservoirs storing glycogen and intracellular lipids with low mitotic activity.
• Proliferative Zone: Chondrocytes align into longitudinal columns parallel to the long axis of the bone, undergoing rapid mitotic division. Matrix synthesis is maximal here, dominated by type II and type XI collagen, aggrecan, and cartilage oligomeric matrix protein (COMP). This zone generates the cellular volume driving linear skeletal growth.
• Hypertrophic Zone: Chondrocytes cease replication and undergo terminal differentiation, enlarging 5- to 10-fold in volume. This layer is sub-divided into the zones of maturation, degeneration, and provisional calcification. Hypertrophic chondrocytes switch matrix production to type X collagen, synthesize matrix metalloproteinases, and release matrix vesicles loaded with tissue-nonspecific alkaline phosphatase (TNAP). In the terminal stratum (Zone of Provisional Calcification), matrix vesicles rupture to seed calcium-hydroxyapatite crystals within the longitudinal septa. Extracellular mineral deposition triggers mitochondrial calcium accumulation, membrane depolarization, and physiological chondrocyte apoptosis.
• Metaphyseal Primary Spongiosa: Capillary loops and perivascular osteoprogenitor cells invade the vacated chondrocytic lacunae. Osteoblasts adhere to the scaffolds of calcified cartilage septa, depositing woven bone osteoid that is subsequently remodeled into mature lamellar trabeculae.

In rickets, the fundamental pathoanatomic lesion resides strictly in the Zone of Provisional Calcification. Because of insufficient extracellular calcium and phosphate ion concentrations, hydroxyapatite crystallization fails to occur. Deprived of the mineral cue, hypertrophic chondrocytes fail to undergo programmed apoptosis. Instead, viable hypertrophic cells persist, lose their columnar polarity, and pile up haphazardly. The hypertrophic zone expands dramatically to 5 to 10 times its physiological thickness. Concurrently, osteoblasts in the adjacent metaphysis continue to synthesize unmineralized type I collagenous matrix (“rachitic osteoid seams”). Under mechanical loading, this uncalcified, compliant chondro-osseous tissue splays, cups, and deforms plastically.

Perichondral Structures and the Extraperiosteal Envelope

The periphery of the physis is stabilized by two specialized fibrocartilaginous structures:

• Perichondral Ring of LaCroix: A dense, circumferential fibrous band continuous with the metaphyseal periosteum and epiphyseal perichondrium. It acts as an external mechanical restraint, resisting shear forces across the compliant cartilaginous disc.
• Ossification Groove of Ranvier: A wedge-shaped circumferential depression containing undifferentiated mesenchymal stem cells and chondroprogenitors that provide continuous latitudinal appositional growth to the physis.

During guided growth procedures (tension-band plating) in metabolic bone disease, strict preservation of these perichondral structures is essential. Surgical dissection must remain strictly extraperiosteal. Incising or cauterizing through the Ring of LaCroix or Groove of Ranvier provokes iatrogenic transphyseal bone bridging, converting a reversible guided growth intervention into an irreversible, progressive angular arrest.

Mechanical Axis Alignment and Joint Orientation Angles

Evaluation and operative planning for rachitic lower extremity malalignment requires standardized full-length standing hip-to-ankle radiographs (teleoroentgenograms) assessing coronal plane vectors:

• Mikulicz Line (Mechanical Axis of the Lower Limb): A straight line projected from the center of the femoral head to the center of the talar dome. Under normal physiological conditions, this vector passes 1.0 to 8.0 mm medial to the midpoint of the knee joint.
• Mechanical Axis Deviation (MAD): The perpendicular distance from the knee joint center to the Mikulicz line. Coronal alignment is divided into Knee Zones: Zone 1 encompasses the central 50% of the knee plateau (25% medial and 25% lateral to midline); Zone 2 encompasses the outer quadrants (25% to 50% from midline); Zone 3 lies entirely outside the joint surface. Progressive rickets drives the MAD into Zone 2 or Zone 3 medially (genu varum) or laterally (genu valgum).
• Mechanical Lateral Distal Femoral Angle (mLDFA): The lateral angle formed between the femoral mechanical axis and the distal femoral articular line. Normal reference value is 87° (physiological range: 85° to 90°). An mLDFA < 85° denotes distal femoral valgus, whereas an mLDFA > 90° indicates distal femoral varus.
• Medial Proximal Tibial Angle (MPTA): The medial angle formed between the tibial mechanical axis and the proximal tibial articular line. Normal reference value is 87° (physiological range: 85° to 90°). An MPTA < 85° denotes proximal tibial varus, whereas an MPTA > 90° indicates proximal tibial valgus.
• Joint Line Congruence Angle (JLCA): The angle subtended by the distal femoral and proximal tibial joint orientation lines. Normal is 0° to 2° of parallel alignment. Values > 2° indicate intra-articular soft-tissue laxity, lateral collateral ligament stretching in genu varum, or medial capsular insufficiency in genu valgum.

Neurovascular Danger Zones and Internervous Planes

Operative correction of lower extremity rachitic deformities exposes critical neurovascular structures to intraoperative trauma and traction injury:

• Common Peroneal (Fibular) Nerve: The nerve courses obliquely around the posterior and lateral aspect of the fibular neck, situated 1.5 to 2.0 cm distal to the lateral tibial joint line beneath the peroneus longus fascia. In acute or rapid correction of severe genu valgum (> 15° to 20°), or during proximal tibial osteotomies, the peroneal nerve is tethered against the unyielding fibular neck. Acute traction produces ischemic neuropraxia or complete axonal disruption. Prophylactic open peroneal nerve decompression (releasing the posterior intermuscular septum and peroneus longus fascia) or gradual spatial frame distraction is mandatory when severe valgus is addressed.
• Popliteal Neurovascular Bundle: The popliteal artery, vein, and tibial nerve lie in direct proximity to the posterior periosteum of the distal femoral metaphysis and proximal tibia. During distal femoral osteotomies, retractors placed along the posterior cortex must stay strictly subperiosteal directly against bone. Placing the knee in 90° of flexion relaxes the gastrocnemius bellies and allows the neurovascular structures to fall posteriorly, providing an expanded safety margin.
• Anterior Tibial Artery: The terminal branch of the popliteal artery traverses anteriorly through the oval aperture in the upper border of the interosseous membrane approximately 4 to 5 cm distal to the tibial plateau. This tethered vascular leash is highly vulnerable to laceration or stretch thrombosis during acute proximal tibial osteotomy or concomitant fibular diaphysectomy.
• Internervous Intervals for Exposure:
  Lateral Distal Femur: The plane between the vastus lateralis (femoral nerve) and the biceps femoris / lateral intermuscular septum (sciatic nerve). Elevating the vastus lateralis anteriorly off the femur avoids denervation.
  Medial Distal Femur: Subvastus elevation of the vastus medialis (femoral nerve) anterior to the adductor magnus tendon and medial intermuscular septum.
  Proximal Anterolateral Tibia: The extraperiosteal interval between the anterior tibial crest and the tibialis anterior muscle belly (deep peroneal nerve).

3. Pathogenesis

Disruption of Endochondral Ossification and Matrix Mineralization

Endochondral ossification requires biological synchronization between chondrocyte differentiation, vascular invasion, and mineralization of extracellular matrix. The critical physicochemical threshold for hydroxyapatite crystal formation ([Ca10(PO4)6(OH)2]) is determined by the ion product of ionized calcium and inorganic phosphate in extracellular fluid ([Ca²⁺] x [Pi]). Matrix vesicles extruded from hypertrophic chondrocytes express tissue-nonspecific alkaline phosphatase (TNAP), which cleaves inorganic pyrophosphate (PPi, a potent endogenous crystallization inhibitor) into orthophosphate (Pi), establishing local supersaturation.

When systemic concentrations of calcium or phosphate fall below this critical saturation product, mineralization is arrested. Deposition of hydroxyapatite into the longitudinal cartilaginous septa is extinguished. Terminal hypertrophic chondrocytes fail to activate the intrinsic apoptotic cascade (which requires phosphate-mediated caspase-9/caspase-3 activation and mitochondrial cytochrome c release). As a consequence, hypertrophic chondrocytes remain metabolically active, continue to expand in volume, and fail to stimulate vascular endothelial growth factor (VEGF)-mediated capillary ingrowth from the metaphyseal bone marrow. Metaphyseal osteoblasts continue to synthesize unmineralized osteoid, generating thick, disorganized rachitic margins unable to withstand physiological shear and bending forces.

The Calcipenic Pathway (Secondary Hypophosphatemia)

Calcipenic rickets originates from inadequate systemic calcium availability, driven by dietary calcium deficiency, vitamin D deficiency, gastrointestinal malabsorption, or genetic enzymatic mutations:

• Nutritional Vitamin D Deficiency: Inadequate cutaneous synthesis of cholecalciferol (secondary to limited ultraviolet B radiation exposure, dark skin pigmentation, or atmospheric pollution) coupled with lack of dietary supplementation. Vitamin D is converted in the liver by 25-hydroxylase (CYP2R1) to 25-hydroxyvitamin D (calcidiol), and subsequently in the renal proximal tubule by 1-alpha-hydroxylase (CYP27B1) to biologically active 1,25-dihydroxyvitamin D (calcitriol).
• Vitamin D-Dependent Rickets Type 1A (VDDR-1A): Autosomal recessive loss-of-function mutations in CYP27B1 (chromosome 12q14.1), resulting in severe 1-alpha-hydroxylase deficiency with undetectable 1,25(OH)2D despite normal or elevated 25(OH)D.
• Vitamin D-Dependent Rickets Type 2A (VDDR-2A): Autosomal recessive mutations in the vitamin D receptor (VDR gene, chromosome 12q13.11), producing end-organ calcitriol resistance. Circulating 1,25(OH)2D levels are markedly elevated, and patients characteristically exhibit total alopecia.

The pathophysiological cascade unfolds in three sequential biochemical stages:

• Stage 1 (Isolated Hypocalcemia): Reduced intestinal calcium absorption decreases ionized serum calcium. Serum phosphate and alkaline phosphatase remain transiently near normal.
• Stage 2 (Secondary Hyperparathyroidism): Hypocalcemia triggers calcium-sensing receptors (CaSR) in the parathyroid glands, stimulating maximal secretion of Parathyroid Hormone (PTH). PTH mobilizes skeletal calcium via osteoclastic resorption and enhances renal tubular calcium reabsorption, restoring serum calcium to the low-normal range. However, PTH strongly internalizes and degrades sodium-phosphate cotransporters (NaPi-IIa [SLC34A1] and NaPi-IIc [SLC34A3]) in the renal proximal tubule, triggering massive urinary phosphate wasting. The resulting profound hypophosphatemia arrests physeal mineralization. Serum alkaline phosphatase rises sharply.
• Stage 3 (Severe Decompensation): Bone mineral reserves are exhausted. Severe hypocalcemia recurs alongside profound hypophosphatemia, elevated PTH, and marked alkaline phosphatase elevation. Radiographic rickets reaches peak severity.

The Phosphopenic Pathway and FGF23 Biology

Phosphopenic rickets results from primary renal phosphate wasting independent of initial parathyroid hormone stimulation, driven primarily by pathological elevations in circulating Fibroblast Growth Factor 23 (FGF23):

• FGF23 Physiological Role: FGF23 is an endocrine phosphatonin secreted by osteocytes and osteoblasts in response to hyperphosphatemia and calcitriol. In the proximal renal tubule, FGF23 binds to the FGFR1 receptor complexed with its obligate transmembrane co-receptor, alpha-Klotho. Signaling via the MAP kinase cascade downregulates apical NaPi-IIa and NaPi-IIc cotransporters, reducing the tubular maximum reabsorption of phosphate per glomerular filtration rate (TmP/GFR) and inducing profound hyperphosphaturia. Simultaneously, FGF23 suppresses CYP27B1 (1-alpha-hydroxylase) and stimulates CYP24A1 (24-hydroxylase), suppressing circulating 1,25(OH)2D levels to inappropriately normal or low values.
• X-Linked Hypophosphatemia (XLH): The most common form of heritable rickets (prevalence 1 in 20,000), caused by loss-of-function mutations in the PHEX gene (phosphate-regulating endopeptidase homolog, X-linked; chromosome Xp22.1). Inactivating PHEX mutations impair local processing and down-regulation of FGF23 transcription in osteocytes, releasing pathological excesses of intact FGF23 into circulation.
• Autosomal Dominant Hypophosphatemic Rickets (ADHR): Gain-of-function missense mutations at the R176 or R179 consensus furin cleavage site of FGF23 (chromosome 12p13.32). These mutations render intact FGF23 resistant to post-translational proteolytic degradation, prolonging its biological half-life and driving chronic renal phosphate wasting.
• Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH): Caused by autosomal recessive mutations in SLC34A3 (encoding NaPi-IIc). Unlike FGF23-mediated disorders, FGF23 is suppressed, and 1-alpha-hydroxylase is maximally stimulated, leading to elevated 1,25(OH)2D, hypercalciuria, and recurrent nephrolithiasis.
• Renal Osteodystrophy / CKD-MBD: Chronic kidney disease stages 4 to 5 (GFR < 30 mL/min/1.73m²) leads to functional nephron loss, phosphate retention (hyperphosphatemia), loss of 1-alpha-hydroxylase, calcitriol deficiency, and hypocalcemia. This induces autonomous parathyroid hyperplasia with secondary or tertiary hyperparathyroidism. Skeletal histology demonstrates mixed features of rickets/osteomalacia and high-turnover osteitis fibrosa cystica.

4. Natural History

Epidemiological Profile and Onset Patterns

The global incidence and phenotypic expression of rickets depend on etiology, socioeconomic conditions, and geographic location. Nutritional rickets predominantly manifests between 6 and 18 months of age, coinciding with the transition to weight-bearing and the depletion of transplacentally acquired vitamin D stores in exclusively breastfed infants receiving no supplemental cholecalciferol. Dark-skinned populations residing at higher latitudes (> 40° N or S) and children with cultural practices limiting sunlight exposure face the greatest risk. In contrast, X-linked hypophosphatemia exhibits an equal sex distribution for gene transmission (though hemizygous males often demonstrate more severe phenotypes) and presents clinically between 12 and 24 months as upright ambulation begins.

Progressive Craniofacial and Thoracic Deformities

If untreated, rickets follows an orderly chronological progression governed by skeletal growth velocity and mechanical stress:

• Craniotabes: The earliest detectable skeletal sign, appearing in infants under 6 months. Unmineralized calvarial bone, predominantly along the parietal and occipital bones, thins and softens, compressing under digit pressure like a ping-pong ball.
• Caput Quadratum and Frontal Bossing: Exuberant, unmineralized osteoid accumulates at the cranial suture lines, generating a box-like skull contour with prominent frontal and parietal eminences, delayed anterior fontanelle closure past 2 years of age, and delayed primary dental eruption with severe enamel hypoplasia.
• Rachitic Rosary: Prominent nodular expansion of the costochondral junctions, most pronounced along the 2nd through 8th ribs, caused by cartilaginous hypertrophy and disorganized osteoid accumulation.
• Harrison Groove (Sulcus): A horizontal thoracic constriction corresponding to the diaphragmatic attachments on softened ribs. Diaphragmatic contraction against unmineralized costal margins pulls the ribs inward, flaring the lower costal margin and causing severe mechanical compliance abnormalities that predispose infants to recurrent atelectasis and pneumonia.

Lower Extremity Malalignment and Skeletal Deformities

The introduction of upright weight-bearing exerts axial and shearing forces across structurally softened metaphyses, producing profound lower limb deformities:

• Early Genu Varum: Toddlers under 2 years of age present with progressive symmetric bowing of the distal femur and proximal tibia. The physiological varus alignment of early childhood fails to resolve, escalating into severe lateral bowing as compliant cortices buckle under body weight.
• Progressive Genu Valgum: In children presenting after age 3 to 4, the developmental transition toward physiological valgus alignment is exaggerated by rachitic physeal compliance, producing severe, debilitating “knock-knee” deformities that lead to circumducting gait deviations and patellar instability.
• Windswept Deformity: Severe asymmetric mechanical loading produces varus deformity in one limb coupled with valgus deformity in the contralateral limb, commonly exacerbated by pelvic obliquity and habitual asymmetrical sitting postures.
• Coxa Vara: Softening of the proximal femoral metaphysis decreases the femoral neck-shaft angle below 120°. This shortens the abductor muscle lever arm, generating a positive Trendelenburg sign and an inefficient, energy-exhausting bilateral waddling gait.
• Pelvic Brim and Spinal Deformities: Inward collapse of the acetabula and sacral promontory produces a narrow, heart-shaped or tri-radiate pelvic aperture, predisposing adult females to cephalopelvic disproportion and obstructed labor. In the spine, poor muscular tone and softened vertebral bodies produce a non-structural thoracolumbar kyphosis (“rachitic cat-back”) that becomes fixed if untreated.

Long-Term Functional Impact

Uncorrected rickets results in permanent short stature characterized by disproportionate rhizomelic and mesomelic lower limb shortening. Persistent coronal and sagittal malalignment causes abnormal joint contact pressures, predisposing patients to early-onset tricompartmental knee osteoarthritis, hip arthrosis, and recurrent Looser zone pseudofractures. In adults with XLH, chronic enthesopathy, ossification of the posterior longitudinal ligament, and spinal canal stenosis produce lifelong pain, stiffness, and ambulatory disability.

5. Clinical Presentation

History

A systematic clinical history must dissect nutritional, environmental, and familial factors:

• Nutritional & Feeding History: Determine the exact duration of exclusive breastfeeding, the daily dose and consistency of infant vitamin D supplementation (inquire if the standard 400 IU daily was prescribed and administered), the timing of complementary food introduction, and dietary calcium sources (dairy intake, fortified foods, or unsupplemented plant-based diets).
• Environmental & Sunlight Exposure: Geographic residence, season of birth, daily outdoor exposure time, sunscreen application habits, and cultural clothing practices involving full-body skin coverage.
• Perinatal & Systemic Medical History: History of prematurity (gestational age < 32 weeks or birth weight < 1500 g predisposes to metabolic bone disease of prematurity), prolonged total parenteral nutrition, chronic diarrhea or steatorrhea (suggestive of celiac disease, cystic fibrosis, or biliary atresia), chronic kidney disease, or anticonvulsant therapy (phenytoin or carbamazepine inducing hepatic cytochrome P450 enzymes that accelerate calcidiol degradation).
• Family Pedigree: Parental heights, presence of lower extremity bowing in siblings or parents, early-onset joint arthroplasty, and spontaneous dental abscesses without visible caries (a hallmark of enlarged pulp chambers in XLH).
• Developmental & Symptomatic Trajectory: Delay in motor milestones, specifically delayed sitting, crawling, and standing past 15 to 18 months of age. Parents report marked lethargy, irritability, reluctance to bear weight, frequent falling, and muscle weakness (hypocalcemic or hypophosphatemic myopathy). In infants with acute calcipenic rickets, inquiry must focus on neuromuscular irritability: carpopedal spasms, perioral numbness, laryngeal stridor, or afebrile seizures.

Physical Exam

Physical examination requires rigorous quantitative assessment of skeletal landmarks and provocative clinical maneuvers:

• Craniotabes: Gentle palpation of the parietal and occipital bones using firm thumb pressure in infants < 6 months -> Ping-pong ball indentation with elastic recoil sensation [Sensitivity 82%, Specificity 88%].
• Rachitic Rosary: Systematic bilateral palpation along the costochondral junctions from the 2nd to 8th ribs -> Symmetrical, non-tender, bead-like nodular enlargement at the costochondral interfaces [Sensitivity 89%, Specificity 94%].
• Harrison Groove: Visual inspection of the lower thoracic margin during quiet respiration -> Transverse horizontal sulcus above the costal margin caused by chronic diaphragmatic pull on softened lower ribs [Sensitivity 74%, Specificity 91%].
• Metaphyseal Widening (Wrists & Ankles): Circumferential palpation of the distal radius, ulna, and distal tibial/fibular malleoli -> Symmetrical, saucer-like transverse flaring and bulbous enlargement of the metaphyses [Sensitivity 92%, Specificity 96%].
• Intercondylar Distance (Genu Varum): Caliper or tape measurement between the medial femoral condyles with patient supine, patellae pointing directly vertical to the ceiling, and medial malleoli touching -> Distance > 5.0 cm (severely pathological if > 7.0 cm) [Sensitivity 88%, Specificity 86%].
• Intermalleolar Distance (Genu Valgum): Caliper or tape measurement between the medial malleoli with patient supine, patellae pointing directly vertical, and medial femoral condyles touching -> Distance > 5.0 cm (severely pathological if > 8.0 cm) [Sensitivity 87%, Specificity 89%].
• Waddling / Trendelenburg Gait: Dynamic observation of barefoot ambulation over a 10-meter level pathway -> Exaggerated lateral trunk lurch and contralateral pelvic drop during stance phase secondary to coxa vara and gluteus medius lever arm insufficiency [Sensitivity 85%, Specificity 78%].
• Chvostek Sign: Light percussion of the facial nerve trunk anterior to the external auditory meatus and inferior to the zygomatic arch -> Unilateral hyperreflexic twitching of facial muscles, specifically the angle of the mouth or orbicularis oculi [Sensitivity 64%, Specificity 98%].
• Trousseau Sign: Sphygmomanometer cuff inflation on the upper arm to 20 mmHg above baseline systolic blood pressure for 3 minutes -> Painful carpal spasm manifesting as wrist and metacarpophalangeal flexion, interphalangeal extension, and thumb adduction (main d’accoucheur) [Sensitivity 94%, Specificity 99%].

6. Imaging and Diagnostic Studies

Plain Radiography

Plain radiography represents the gold standard for confirming rickets, staging skeletal severity, and directing deformity correction. Standard radiographic projections include full-length standing hip-to-ankle teleoroentgenograms (with patellae positioned strictly forward to eliminate rotational distortion) and dedicated anteroposterior and lateral radiographs of the wrists and knees.

The classical radiographic presentation comprises four cardinal metaphyseal and physeal signs:

• Physeal Widening: Transverse and longitudinal expansion of the radiolucent space between the epiphyseal ossification center and the metaphysis, representing accumulation of uncalcified hypertrophic chondrocytes.
• Metaphyseal Cupping: Concave, goblet-like depression of the metaphyseal margin, as the structurally compliant metaphysis is compressed around the expanding cartilaginous physis under axial weight-bearing.
• Metaphyseal Fraying: Loss of the razor-sharp zone of provisional calcification, replaced by an indistinct, brush-like, irregular border formed by disorganized osteoid projections and microfractures.
• Metaphyseal Splaying: Transverse flaring and widening of the metaphyseal margin beyond the normal cortical margins, creating a characteristic trumpet-bell contour.

Additional pathognomonic radiographic features include:

• Looser Zones (Milkman Pseudofractures): Narrow, transverse radiolucent bands oriented perpendicular to the bone cortex, accompanied by sclerotic margins. These represent cortical microstress fractures repaired with unmineralized osteoid rather than true traumatic disruptions. Classical locations include the medial femoral neck, medial proximal tibia, proximal femoral diaphysis, superior and inferior pubic rami, and the axillary border of the scapula.
• Mechanical Axis Deformity Parameters: Quantification of mechanical axis deviation (MAD, normal 1.0 to 8.0 mm medial), mechanical lateral distal femoral angle (mLDFA, normal 87°), medial proximal tibial angle (MPTA, normal 87°), and joint line congruence angle (JLCA, normal 0° to 2°).

Biochemical Profile

Comprehensive laboratory evaluation distinguishes calcipenic from phosphopenic rickets and identifies specific enzymatic and receptor defects:

Advanced Diagnostics & Genetic Testing

When nutritional rickets is excluded by normal 25(OH)D concentrations or refractoriness to vitamin D repletion, advanced testing is required:

• Next-Generation Sequencing (NGS) Panels: Targeted multigene panels including PHEX (XLH), FGF23 (ADHR), DMP1 (ARHR1), ENPP1 (ARHR2), CYP27B1 (VDDR-1A), CYP2R1 (VDDR-1B), VDR (VDDR-2A), SLC34A1 (NaPi-IIa), and SLC34A3 (HHRH). Genetic confirmation is critical for guiding targeted biologic therapy and familial counseling.
• Circulating FGF23 Assays: Intact FGF23 (iFGF23) ELISA and C-terminal FGF23 (cFGF23) assays. In XLH and ADHR, circulating intact FGF23 is elevated or inappropriately normal despite severe hypophosphatemia, whereas in HHRH and nutritional rickets, FGF23 is appropriately suppressed.
• Tubular Maximum Reabsorption of Phosphate per GFR (TmP/GFR): Calculated from simultaneous fasting spot morning blood and urine samples for phosphate and creatinine using the formula:
  Tubular Reabsorption of Phosphate (TRP) = 1 – [(Urine Phosphate x Serum Creatinine) / (Serum Phosphate x Urine Creatinine)].
  If TRP ≤ 0.86: TmP/GFR = TRP x Serum Phosphate.
  If TRP > 0.86: TmP/GFR = [0.3 x TRP / (1 – 0.8 x TRP)] x Serum Phosphate.
  A low TmP/GFR plotted on the age-adjusted Walton-Bijvoet nomogram confirms renal phosphate wasting.
• Dual-Energy X-ray Absorptiometry (DEXA) Caveats: In children with active rickets, areal bone mineral density (BMD) is systematically underestimated due to short stature, bone size artifacts, and delayed mineralization. DEXA Z-scores must be adjusted for height-age; unadjusted scores provide misleading estimates of fracture risk.

7. Classification

Etiological Classification

Modern clinical management classifies rickets according to its primary biochemical mechanism: calcipenic rickets, phosphopenic rickets, or chronic renal tubular disease:

Radiographic Severity Staging: The Thacher Rickets Severity Score (RSS)

The Thacher Rickets Severity Score (RSS) is a validated 10-point scoring tool based on posteroanterior radiographs of the wrists and anteroposterior views of the knees, quantifying the degree of physeal cupping, fraying, and loss of provisional calcification:

8. Treatment

Medical / Pharmacologic Management

Medical management represents the foundational therapy for all forms of rickets. Pharmacotherapy is tailored directly to the specific biochemical etiology:

• Calcipenic Nutritional Rickets:
  Cholecalciferol (Vitamin D3) Therapy: Cholecalciferol is superior to ergocalciferol (D2) in sustaining serum 25(OH)D concentrations. Daily dosing is preferred: 2,000 IU (50 mcg) daily for 12 weeks, followed by lifelong daily maintenance of 400 to 1,000 IU. For non-compliant patients, single-dose or divided “stoss” therapy (100,000 to 300,000 IU orally over 1 to 2 days) provides rapid remineralization.
  Mandatory Elemental Calcium Co-Prescription: All vitamin D protocols must be co-administered with elemental calcium (500 to 1,000 mg daily or 30 to 75 mg/kg/day in divided doses). In the absence of concurrent calcium supplementation, rapid skeletal remineralization acts as an acute calcium sink, triggering life-threatening hypocalcemia, tetany, laryngospasm, or seizures (“Hungry Bone Syndrome”).
• Vitamin D-Dependent Rickets (VDDR):
  VDDR-1A: Calcitriol (1,25-dihydroxyvitamin D3) administered at 15 to 50 ng/kg/day in two divided doses, combined with maintenance elemental calcium (30 to 50 mg/kg/day).
  VDDR-2A: Massive doses of calcitriol (up to 2 to 5 mcg daily) combined with high-dose oral elemental calcium (1,000 to 3,000 mg daily). If oral therapy fails to correct hypocalcemia, long-term intracaval calcium infusions via a tunneled central venous catheter are required.
• Phosphopenic X-Linked Hypophosphatemia (XLH):
  Targeted Biologic Therapy (Burosumab): Burosumab is a fully human monoclonal IgG1 antibody that binds and neutralizes intact circulating FGF23. Administered subcutaneously every 2 weeks at a starting dose of 0.8 mg/kg (titrated up to 2.0 mg/kg; maximum 90 mg) targeting a fasting serum phosphate in the lower normal range for age. Burosumab restores renal tubular phosphate reabsorption (TmP/GFR), stimulates 1,25(OH)2D production, normalizes linear growth velocity, and heals the rachitic physis without inducing hypercalciuria or nephrocalcinosis.
  Conventional Therapy (Oral Phosphate + Calcitriol): When burosumab is inaccessible, conventional therapy consists of oral elemental phosphorus (20 to 40 mg/kg/day divided into 4 to 6 daily doses due to rapid urinary excretion) combined with active calcitriol (20 to 30 ng/kg/day). Close surveillance is mandatory: excessive phosphate triggers tertiary hyperparathyroidism, while excessive calcitriol causes hypercalciuria and nephrocalcinosis.

Operative Management

Surgical intervention for rachitic limb deformity is indicated only for persistent structural malalignment that fails to remodel after exhaustive medical therapy. Operative principles follow strict biological and mechanical rules:

• The Mandatory Preoperative Metabolic Stabilization Rule: Operating on an active, metabolically unhealed rachitic skeleton is an absolute surgical error. Unmineralized osteoid possesses poor biomechanical integrity; screws tear through soft cortex, osteotomy sites develop catastrophic nonunion, and deformities rapidly recur. Elective surgical intervention must be deferred until serum alkaline phosphatase and parathyroid hormone have normalized, serum calcium and phosphate are stable, and standing long-leg radiographs demonstrate continuous reconstitution of the razor-sharp zone of provisional calcification (requiring a minimum of 6 to 12 months of verified medical quiescence).
• Guided Growth / Temporary Hemiepiphysiodesis: The first-line surgical procedure for progressive coronal deformities in growing children with open physes (minimum 1 to 2 years of remaining growth). Extraperiosteal tension-band plates (two-hole non-locking plates / eight-plates) are placed across the physis on the convex side of the deformity:
  Genu Valgum: Medial distal femoral plate and/or medial proximal tibial plate.
  Genu Varum: Lateral distal femoral plate and/or lateral proximal tibial plate.
  Technical Pearls in Metabolic Bone Disease: Dissection must remain strictly extraperiosteal without incising the perichondral Ring of LaCroix to prevent permanent asymmetric physeal bridge formation. Solid cortical screws or diverging cannulated screws (30° to 40° divergence) must be utilized to optimize purchase in softened bone. Because correction velocity is slower (0.5° to 0.7° per month) and rebound deformity occurs in over 30% of XLH cases, guided growth must intentionally overcorrect the mechanical axis by 2° to 3° into the contralateral compartment prior to hardware removal.
• Corrective Osteotomy (Acute vs. Gradual): Indicated for skeletally mature adolescents, severe multiplanar deformities (> 20° to 30° angulation with rotational or translational components), failed guided growth, or multiapical deformities.
  Acute Correction with Internal Fixation: Transverse, closing-wedge, or focal dome osteotomies secured with rigid locked plating or intramedullary rodding. In pediatric patients with severe diaphyseal femoral/tibial bowing and osteopenia, telescoping intramedullary rods (Fassier-Duval rods) provide internal splinting that elongates with growth, preventing recurrent diaphyseal refracture.
  Gradual Correction with Circular External Fixation (Taylor Spatial Frame / Ilizarov): Indicated for severe multiapical deformities, multiplanar deformities associated with limb length discrepancy > 2.0 cm, or severe genu valgum (> 15° to 20°) where acute correction places the tethered common peroneal nerve at risk of traction neuropraxia. Following low-energy percutaneous corticotomy in metabolically consolidated bone, a 7- to 10-day latency period is observed prior to initiating distraction at 0.75 to 1.0 mm/day.

Surgical Indications & Thresholds

Operative intervention is governed by explicit quantitative thresholds:

• Clinical Intercondylar / Intermalleolar Distance: Persistent intercondylar distance > 7.0 cm (genu varum) or intermalleolar distance > 8.0 cm (genu valgum) in children ≥ 3 to 4 years of age.
• Mechanical Axis Deviation (MAD): Persistence of the mechanical axis within Zone 2 or Zone 3 (medially or laterally) on standing hip-to-ankle teleoroentgenograms following a minimum of 12 months of continuous, verified medical compliance and biochemical healing.
• Joint Orientation Thresholds: Mechanical lateral distal femoral angle (mLDFA) < 80° (distal femoral valgus) or > 95° (distal femoral varus); Medial proximal tibial angle (MPTA) < 80° (proximal tibial varus) or > 95° (proximal tibial valgus).
• Functional Indicators: Recurrent patellar dislocation or lateral subluxation, progressive joint pain, gait fatigue, or refractory stress pseudofractures (Looser zones) that fail to unite under optimal medical therapy.
• Contraindications:
  Absolute: Active, unhealed rickets characterized by elevated alkaline phosphatase, widened physes, and unmineralized osteoid seams.
  Relative: Skeletal maturity (contraindication for guided growth); active systemic infection; uncorrected severe secondary hyperparathyroidism.

9. Outcome

Clinical and structural outcomes in rickets depend on underlying genetic etiology, timing of medical initiation, and adherence to metabolic stabilization protocols:

• Physeal Remodeling and Correction Velocities: In nutritional rickets, mild to moderate coronal deformities (MAD in Zone 1 or inner Zone 2) demonstrate spontaneous remodeling capacity once 25(OH)D and calcium are restored. In genetic rickets (XLH), spontaneous remodeling is absent. Guided growth via tension-band plates achieves an average coronal angular correction rate of 0.5° to 0.7° per month. This velocity is significantly slower than the 0.9° to 1.2° per month observed in non-metabolic idiopathic genu valgum/varum. Median time to full mechanical axis realignment ranges from 14 to 22 months.
• Rebound Deformity Dynamics: Rebound deformity occurs in 30% to 42% of pediatric XLH patients following hardware removal, driven by ongoing subclinical metabolic disturbance, growth spurts, and fluctuating medical adherence. Intentionally overcorrecting the mechanical axis by 2° to 3° into the contralateral compartment reduces the need for revision guided growth.
• Burosumab vs. Conventional Therapy Endpoints: Landmark prospective randomized trials demonstrate that burosumab produces significantly greater reductions in the Thacher Rickets Severity Score (mean RSS reduction of 2.1 points at 40 weeks compared to 0.8 points with oral phosphate and calcitriol). Burosumab therapy yields substantial increases in standing height Z-scores (+0.17 to +0.35 SD) and corrects lower extremity bowing without increasing nephrocalcinosis scores.
• Functional and Patient-Reported Outcome Measures (PROMs): Medical healing and surgical alignment restore functional ambulation. The 6-Minute Walk Test (6MWT) demonstrates statistically and clinically significant distance gains of > 60 to 80 meters. Pediatric Outcomes Data Collection Instrument (PODCI) and PedsQL metrics show marked improvements in sports and physical functioning, pain and comfort, and global health domains.

10. Complications

Complications in rickets divide into pharmacotherapy-related medical toxicities and surgical pitfalls:

11. Pearls and Pitfalls

Diagnostic and Preoperative Pearls

• Alkaline Phosphatase is the Sensitive Sentinel: Serum alkaline phosphatase (ALP) is the earliest biomarker to rise during rachitic onset, preceding radiographic abnormalities by months, and the last parameter to normalize during healing. Never diagnose or declare rickets healed based solely on plain radiographs; biochemical normalization of ALP is the true arbiter of histological recovery.
• The “6-Month Quiescence Rule”: Never perform elective deformity correction surgery until the patient has maintained documented biochemical remission (normalized ALP, normal PTH, normal Ca x P product) for a minimum of 6 to 12 consecutive months, with full radiographic consolidation of the zone of provisional calcification. Cutting or instrumenting softened rachitic bone guarantees hardware pullout and nonunion.
• The Spot Urine Screening Clue: In a toddler presenting with progressive lower extremity bowing, normal serum calcium, and normal 25(OH)D, immediately order fasting serum phosphate and a spot urine phosphate-to-creatinine ratio. A low serum phosphate paired with high urinary phosphate excretion confirms FGF23-mediated phosphaturia (XLH), differentiating it from physiological bowing or Blount disease.

Technical Intraoperative Pearls

• Strict Extraperiosteal Tension-Band Placement: During guided growth, position tension-band plates strictly on top of the periosteum. Elevating the periosteum or incising the fibrocartilaginous Ring of LaCroix induces permanent transphyseal bone bridging in metabolic bone disease.
• Screw Divergence and Thread Purchase: Diverge epiphyseal and metaphyseal screws by 30° to 40° to optimize mechanical purchase in osteopenic bone. In softened bone, solid cortical screws frequently provide superior torque and thread grip compared to cannulated screws.
• Intentional Overcorrection: When performing guided growth for genu varum or valgum in children with XLH, do not remove the hardware at the exact moment the mechanical axis touches the center of the knee. Deliberately overcorrect the mechanical axis by 2° to 3° into the contralateral compartment (Zone 1) to build a protective buffer against post-removal rebound deformity.

Clinical and Surgical Pitfalls to Avoid

• The Unsupplemented High-Dose Vitamin D Trap: Administering high-dose cholecalciferol (“stoss” therapy) without concurrent oral elemental calcium is a life-threatening pitfall. Rapidly remineralizing bone acts as an avid calcium sponge, driving acute profound hypocalcemia, tetany, and cardiac arrest (Hungry Bone Syndrome).
• Acute Valgus Correction Without Peroneal Release: Performing acute osteotomy or aggressive acute correction of severe genu valgum (> 15° to 20°) without prophylactic open release of the common peroneal nerve risks traction-induced ischemic foot drop.
• Misdiagnosing XLH as Tibia Vara (Blount Disease): Children with XLH presenting with severe tibia vara are frequently misdiagnosed as infantile Blount disease. Performing a proximal tibial osteotomy in an unrecognized, untreated XLH patient leads to catastrophic nonunion, hardware failure, and immediate recurrence. Always check serum alkaline phosphatase and phosphate in atypical tibia vara.

12. Controversy

Guided Growth vs. Corrective Osteotomy in Metabolic Bone Disease

Substantial debate surrounds the optimal surgical modality for correcting progressive coronal malalignment in pediatric metabolic bone disease. Historically, corrective osteotomies carried nonunion rates of 20% to 50%, infection risks, and deformity recurrence rates exceeding 60%. While guided growth using tension-band plates has transformed pediatric orthopaedic practice due to its minimally invasive, outpatient profile and low morbidity, critics highlight that rachitic physes respond at half the velocity of idiopathic physes (0.5° vs. 1.0° per month) and suffer from rebound deformity rates of 30% to 42% following hardware removal. Contemporary consensus favors guided growth as the definitive first-line intervention in children with at least 1 to 2 years of remaining physeal growth, reserving corrective osteotomy with circular spatial frames for severe multiplanar deformities near skeletal maturity.

First-Line Burosumab vs. Conventional Therapy in Pediatric XLH

The introduction of burosumab has established a paradigm shift in the medical management of X-linked hypophosphatemia. Conventional therapy with oral phosphate and calcitriol requires strict dosing every 4 to 6 hours, provides incomplete skeletal healing, and carries high cumulative risks of nephrocalcinosis and tertiary hyperparathyroidism. Burosumab directly neutralizes excess circulating FGF23, restoring physiological renal phosphate conservation and promoting superior physeal healing and linear growth. However, health-economic barriers are profound: burosumab costs approximately $200,000 to $400,000 annually per pediatric patient and requires biweekly subcutaneous injections throughout growth. Intense debate continues regarding whether all diagnosed children should receive upfront burosumab, or whether it should be reserved for patients exhibiting radiographic rickets severity scores ≥ 1.5, severe bowing, or nephrocalcinosis on conventional therapy.

Complete Hardware Removal vs. “Unhinging” in Guided Growth

Following successful mechanical axis realignment via tension-band plating, surgeons disagree on whether to completely explant the plate or perform an “unhinging” procedure (removing only the metaphyseal screw while leaving the plate and epiphyseal screw in situ under the deep fascia). Advocates of unhinging argue that in patients with high rebound risk (30% to 40%), leaving the hardware in place allows rapid, minimally invasive re-insertion of a single metaphyseal screw under local sedation when rebound occurs. Opponents contend that retained hardware risks cold welding, screw stripping during secondary extraction, bursal irritation, and soft-tissue scarring that may tether the perichondral ring.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Munns CF, Shaw N, Kiely M et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016. doi:10.1210/jc.2015-2175 [Level I: Clinical Consensus / Practice Guideline]
• Carpenter TO, Whyte MP, Imel EA et al. Burosumab Therapy in Children with X-Linked Hypophosphatemia. N Engl J Med. 2018. doi:10.1056/NEJMoa1714641 [Level I: Randomized Controlled Trial]
• Haffner D, Emma F, Eastwood DM et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019. doi:10.1038/s41581-019-0152-5 [Level I: Clinical Consensus / Practice Guideline]
• ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000. doi:10.1038/81664 [Level IV: Clinical Cohort / Genetic Investigation]
• Cranney A, Horsley T, O’Donnell S et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007. doi:PMID:18088161 [Level I: Systematic Review / Meta-Analysis]
• Wagner CL, Greer FR, American Academy of Pediatrics Section on Breastfeeding, American Academy of Pediatrics Committee on Nutrition. Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents. Pediatrics. 2008. doi:10.1542/peds.2008-1862 [Level IV: Clinical Consensus / Policy Statement]
• Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006. doi:10.1172/jci29449 [Level IV: Clinical Review / Physiological Analysis]
• Yeung WG, Palmer SC, Strippoli GFM et al. Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2023. doi:10.1053/j.ajkd.2023.04.003 [Level I: Systematic Review / Meta-Analysis]

15. Master Class Pro-Tip

Deformity correction in metabolic bone disease must never be approached as an isolated mechanical exercise. The biology strictly dictates the surgical outcome: any hardware inserted into unmineralized, active rachitic osteoid will fail through screw loosening or cut-out, and osteotomies cut through active physes will develop catastrophic nonunions. Always demand a minimum of 6 to 12 months of biochemical quiescence—characterized by normalized serum alkaline phosphatase, stable calcium-phosphate balance, and radiographic reconstitution of the razor-sharp zone of provisional calcification—before touching the limb. When performing guided growth, position tension-band plates strictly extraperiosteal without violating the perichondral ring of LaCroix, diverge your screws to optimize purchase in softened bone, and deliberately overcorrect the mechanical axis by 2° to 3° into the contralateral compartment before implant removal to insulate the child against the inevitable rebound phenomenon.

Master Class Surgical Pearl: Pediatric Deformity Correction in Metabolic Bone Disease